Aimmune Therapeu Shares Down 54.6% Since SmarTrend's Sell Call (AIMT)
March 25, 2020 at 01:07 AM EDT
SmarTrend identified a Downtrend for Aimmune Therapeu (NASDAQ:AIMT) on February 6th, 2020 at $29.72. In approximately 2 months, Aimmune Therapeu has returned 54.56% as of today's recent price of...